366 related articles for article (PubMed ID: 10772976)
21. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.
Bagai S; Lamb RA
J Virol; 1995 Nov; 69(11):6712-9. PubMed ID: 7474081
[TBL] [Abstract][Full Text] [Related]
22. Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion.
Tsurudome M; Kawano M; Yuasa T; Tabata N; Nishio M; Komada H; Ito Y
Virology; 1995 Oct; 213(1):190-203. PubMed ID: 7483263
[TBL] [Abstract][Full Text] [Related]
23. Mutations in multiple domains activate paramyxovirus F protein-induced fusion.
Seth S; Goodman AL; Compans RW
J Virol; 2004 Aug; 78(16):8513-23. PubMed ID: 15280460
[TBL] [Abstract][Full Text] [Related]
24. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion.
Russell CJ; Jardetzky TS; Lamb RA
EMBO J; 2001 Aug; 20(15):4024-34. PubMed ID: 11483506
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis for naturally occurring elevated readthrough transcription across the M-F junction of the paramyxovirus SV5.
Rassa JC; Parks GD
Virology; 1998 Aug; 247(2):274-86. PubMed ID: 9705920
[TBL] [Abstract][Full Text] [Related]
26. A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death.
Takaguchi M; Takahashi T; Hosokawa C; Ueyama H; Fukushima K; Hayakawa T; Itoh K; Ikeda K; Suzuki T
J Biochem; 2011 Feb; 149(2):191-202. PubMed ID: 21186250
[TBL] [Abstract][Full Text] [Related]
27. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike.
Deng R; Wang Z; Mirza AM; Iorio RM
Virology; 1995 Jun; 209(2):457-69. PubMed ID: 7778280
[TBL] [Abstract][Full Text] [Related]
28. Effects of adenovirus-mediated SV5 fusogenic glycoprotein expression on tumor cells.
Gómez-Treviño A; Castel S; López-Iglesias C; Cortadellas N; Comas-Riu J; Mercadé E
J Gene Med; 2003 Jun; 5(6):483-92. PubMed ID: 12797113
[TBL] [Abstract][Full Text] [Related]
29. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
Ortiz MA; Paez E
Virology; 1994 Jan; 198(1):155-68. PubMed ID: 8259650
[TBL] [Abstract][Full Text] [Related]
30. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein.
Russell R; Paterson RG; Lamb RA
Virology; 1994 Feb; 199(1):160-8. PubMed ID: 8116239
[TBL] [Abstract][Full Text] [Related]
31. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins.
Heminway BR; Yu Y; Galinski MS
Virus Res; 1994 Jan; 31(1):1-16. PubMed ID: 8165862
[TBL] [Abstract][Full Text] [Related]
32. Conserved leucine residue in the head region of morbillivirus fusion protein regulates the large conformational change during fusion activity.
Plattet P; Langedijk JP; Zipperle L; Vandevelde M; Orvell C; Zurbriggen A
Biochemistry; 2009 Sep; 48(38):9112-21. PubMed ID: 19705836
[TBL] [Abstract][Full Text] [Related]
33. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling.
Young JK; Hicks RP; Wright GE; Morrison TG
Virology; 1997 Nov; 238(2):291-304. PubMed ID: 9400602
[TBL] [Abstract][Full Text] [Related]
34. Effects of multiple amino acids of the parainfluenza virus 5 fusion protein on its haemagglutinin-neuraminidase-independent fusion activity.
Ito M; Nishio M; Kawano M; Komada H; Ito Y; Tsurudome M
J Gen Virol; 2009 Feb; 90(Pt 2):405-413. PubMed ID: 19141450
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion.
Deng R; Wang Z; Mahon PJ; Marinello M; Mirza A; Iorio RM
Virology; 1999 Jan; 253(1):43-54. PubMed ID: 9887317
[TBL] [Abstract][Full Text] [Related]
36. Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion.
Heminway BR; Yu Y; Tanaka Y; Perrine KG; Gustafson E; Bernstein JM; Galinski MS
Virology; 1994 May; 200(2):801-5. PubMed ID: 8178462
[TBL] [Abstract][Full Text] [Related]
37. Engineering of a parainfluenza virus type 5 fusion protein (PIV-5 F): development of an autonomous and hyperfusogenic protein by a combinational mutagenesis approach.
Terrier O; Durupt F; Cartet G; Thomas L; Lina B; Rosa-Calatrava M
Virus Res; 2009 Dec; 146(1-2):115-24. PubMed ID: 19770012
[TBL] [Abstract][Full Text] [Related]
38. Individual roles of N-linked oligosaccharide chains in intracellular transport of the paramyxovirus SV5 fusion protein.
Bagai S; Lamb RA
Virology; 1995 May; 209(1):250-6. PubMed ID: 7747477
[TBL] [Abstract][Full Text] [Related]
39. Effects of ectodomain sequences between HR1 and HR2 of F1 protein on the specific membrane fusion in paramyxoviruses.
Ren G; Wang Z; Hu X
Intervirology; 2007; 50(2):115-22. PubMed ID: 17191013
[TBL] [Abstract][Full Text] [Related]
40. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.
Yao Q; Hu X; Compans RW
J Virol; 1997 Jan; 71(1):650-6. PubMed ID: 8985396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
